Clinical Trials
29 trialsComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
DEBBRAH
MedSIR
EBRAIN-MEL
Grupo Español Multidisciplinar de Melanoma
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors
M.D. Anderson Cancer Center
SNIPP
University Health Network, Toronto
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Wake Forest University Health Sciences
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
Albert Einstein College of Medicine
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
GRAY-B
Grupo Español Multidisciplinar de Melanoma
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Alliance for Clinical Trials in Oncology
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
National Institutes of Health Clinical Center (CC)
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
Duke University
Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
University of California, San Francisco
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
Radiation Therapy Oncology Group
NRR
UNC Lineberger Comprehensive Cancer Center
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Ohio State University Comprehensive Cancer Center
A Phase II Study of Dacomitinib in Progressive Brain Metastases
University of California, San Diego
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
Memorial Sloan Kettering Cancer Center
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma
Memorial Sloan Kettering Cancer Center
Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
Case Comprehensive Cancer Center
Epothilone B in Treating Patients With CNS Metastases From Breast Cancer
Case Comprehensive Cancer Center
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Duke University